Most Recent
Aristocrat has fended off the Commissioner of Patents' challenge to a finding that its Lightning Link poker machine is capable of being patented, with the High Court declining to weigh in on the patent for a second time.
Danish company Vestesen Hybrid Energy has taken Zenith Energy to court for allegedly infringing its patented system for operating an electrical grid where energy is generated by a fluctuating renewable energy source.
A hearing on the relief Fortnite maker Epic Games is entitled to in its successful competition case against Google and Apple could be affected by a hearing on a worldwide settlement reached by Google, a judge has said.
Class action settlements hit major milestones last year, with the year’s largest settlements totalling $1.6 billion and one case resolving for a historic $548.5 million.
A judge has ordered ANZ to pay $250 million in penalties in four cases by ASIC – $10 million more than the bank had agreed to pay – saying ANZ had "substantially deceived” the government by overstating bond trading volumes.
Orders proposed by Apple after a judge’s finding that the digital giant and rival Google engaged in anti-competitive conduct would “rob the court’s findings of their detail, their efficacy and their bite”, Epic Games has said.
Fresh off a record settlement for the Robodebt scandal, the government is facing a new class action over a law that retroactively allowed it to impose card payment surcharges, which the suit says amounts to unjust enrichment.
AMP has agreed to pay $29 million to settle a class action alleging insurance customers were overcharged, putting to rest another case stemming from "serious misconduct" that came to light curing the 2018 banking royal commission.
A judge has questioned whether an agreed penalty against ANZ for overstating bond trading volumes is sufficient, noting the misrepresentations were "very significant".
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea.